home / stock / seer / seer news


SEER News and Press, Seer Inc. From 08/10/22

Stock Information

Company Name: Seer Inc.
Stock Symbol: SEER
Market: NASDAQ
Website: seer.bio

Menu

SEER SEER Quote SEER Short SEER News SEER Articles SEER Message Board
Get SEER Alerts

News, Short Squeeze, Breakout and More Instantly...

SEER - Seer, Inc. (SEER) Q2 2022 Earnings Call Transcript

Image source: The Motley Fool. Seer, Inc. (NASDAQ: SEER) Q2 2022 Earnings Call Aug 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Seer, Inc. (SEER) Q2 2022 Earnings Call Transcript

SEER - Seer stock tumbles aftermarket despite in-line Q2 earnings

Seer ( NASDAQ: SEER ) stock tumbled 14.6% postmarket Tuesday despite the life sciences firm's largely in-line Q2 results . SEER reported Q2 GAAP EPS of -$0.37 vs. -$0.27 in Q2 2021. Revenue more than doubled to $3.6M, led by higher sales of the Proteograph Pro...

SEER - Seer Q2 GAAP EPS, revenue beats, guidance affirmed

Seer press release ( NASDAQ: SEER ): Q2 GAAP EPS of -$0.37 (vs. -$0.27 Y/Y) beats by $0.01 . Revenue of $3.6M (+170.7% Y/Y) beats by $0.34M . Seer continues to expect full year 2022 revenue to be in the range of $14.0 million to $16.0 million. Consensus estimat...

SEER - Seer Reports Second Quarter 2022 Financial Results

REDWOOD CITY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the second quarter ended June 30, 2022. “We are building on a strong start t...

SEER - Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph(TM) Analysis Suite 2.0

REDWOOD CITY, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced a new Proteogenomics Workflow that integrates deep, unbiased proteomics with genomics, powered by the Proteogra...

SEER - Seer to Report Second Quarter 2022 Financial Results on August 9, 2022

REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the second quarter of 2022 on Tuesday, August 9, 2022. Company management ...

SEER - Lantheus Holdings Rules The Medical Diagnostics Business World

Which of the healthcare producers of Diagnostic Solutions is now a better buy to help build your portfolio’s near-term capital value? Near-term only, repetition provides long term. Here find out what the best-informed, big-$ investors now think is likely to happen (good and bad...

SEER - Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)

- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business Combination Agreement with DYNS - - DYNS announces effectiveness of registration statem...

SEER - Seer, Inc. (SEER) CEO Omid Farokhzad on Q1 2022 Results - Earnings Call Transcript

Seer, Inc. (SEER) Q1 2022 Earnings Conference Call May 04, 2022, 05:00 PM ET Company Participants Carrie Mendivil - IR Omid Farokhzad - Founder, Chairman & CEO David Horn - CFO Omead Ostadan - President Conference Call Participants Neil Vibhakar - Morgan Stanley Nisarg Shah - Bank of Amer...

SEER - Seer, Inc. (SEER) Q1 2022 Earnings Call Transcript

Image source: The Motley Fool. Seer, Inc. (NASDAQ: SEER) Q1 2022 Earnings Call May 04, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Seer, Inc. (SEER) Q1 2022 Earnings Call Transcript

Previous 10 Next 10